Table 3.
Clinical composition of different service sectors and prediction of 12-month service use
| GM Onlya (n = 372) | SMH Onlya (n = 342) | GM + SMHa (n = 157) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| % | (se) | OR | (95% CI) | % | (se) | OR | (95% CI) | % | (se) | OR | (95% CI) | |
| Disorder type | ||||||||||||
| Any anxiety (χ2 for tx type = 8.2*c) | 42.3 | (3.1) | 4.7* | (3.6–6.1) | 58.1 | (2.6) | 3.9* | (3.0–5.2) | 60.5 | (3.5) | 9.8* | (7.2–13.3) |
| Any mood (χ2 for tx type = 22.8*c) | 26.9 | (2.3) | 6.2* | (4.8–8.2) | 28.5 | (2.4) | 6.8* | (5.2–8.7) | 51.9 | (3.3) | 18.3* | (13.9–24.2) |
| Any impulse (χ2 for tx type = 3.2c) | 10.6 | (1.4) | 2.4* | (1.6–3.5) | 13.9 | (1.9) | 3.2* | (2.4–4.6) | 16.5 | (2.6) | 4.0* | (2.6–6.0) |
| Any substance (χ2 for tx type=6.3 *c) | 4.9 | (1.2) | 1.7 | (1.0–2.7) | 10.5 | (1.7) | 3.8* | (2.7–5.4) | 13.7 | (2.2) | 5.2* | (3.8–7.1) |
| χ24b | 330.1* | 431.0* | 446.2* | |||||||||
| χ26 for Treatment Type=21.7*c | ||||||||||||
| Number of mental health disorders | ||||||||||||
| 0 | 42.5 | (2.5) | 1.0 | -- | 42.7 | (2.0) | 1.0 | -- | 21.3 | (3.4) | 1.0 | -- |
| 1 | 28.5 | (2.1) | 4.5* | (3.5–5.8) | 23.7 | (1.7) | 3.7* | (2.8–4.8) | 25.5 | (3.4) | 8.0* | (4.8–13.3) |
| 2 | 13.7 | (1.6) | 6.0* | (4.4–8.2) | 14.2 | (1.5) | 6.1* | (4.3–8.9) | 17.5 | (2.6) | 15.2* | (8.6–26.7) |
| 3+ | 15.3 | (1.7) | 7.9* | (5.8–10.7) | 19.4 | (1.7) | 9.9* | (7.8–12.8) | 35.7 | (3.8) | 36.8* | (24.0–56.4) |
| χ23b | 252.4* | 389.0* | 309.9* | |||||||||
| χ26 for Treatment Type=1.0c | ||||||||||||
| Mental health disorder severity | ||||||||||||
| None | 40.5 | (2.7) | 1.0 | -- | 38.2 | (2.1) | 1.0 | -- | 19.7 | (3.3) | 1.0 | -- |
| Mild | 20.5 | (2.1) | 4.1* | (3.0–5.7) | 13.9 | (1.8) | 3.0* | (2.1–4.3) | 13.3 | (3.3) | 5.5* | (2.8–11.0) |
| Moderate | 24.5 | (1.8) | 6.0* | (4.7–7.8) | 21.8 | (1.9) | 5.7* | (4.4–7.3) | 27.0 | (3.2) | 13.6* | (8.9–20.7) |
| Severe | 14.5 | (1.5) | 8.8* | (6.6–11.8) | 26.1 | (2.6) | 16.8* (12.2–23.2) | 40.0 | (4.0) | 50.0* | (31.7–78.7) | |
| χ23b | 318.4* | 393.8* | 394.9* | |||||||||
| χ26 for Treatment Type=55.2*c | ||||||||||||
| Number of chronic conditions | ||||||||||||
| 0–1 | 24.0 | (2.9) | 1.0 | -- | 38.9 | (2.8) | 1.0 | -- | 29.3 | (2.8) | 1.0 | -- |
| 2–3 | 37.3 | (2.6) | 2.2* | (1.6–3.2) | 37.2 | (2.6) | 1.4* | (1.1–1.8) | 40.9 | (3.8) | 2.0* | (1.5–2.8) |
| 4+ | 38.7 | (2.6) | 4.7* | (3.3–6.7) | 23.9 | (2.5) | 1.8* | (1.3–2.5) | 29.7 | (3.4) | 3.0* | (2.1–4.1) |
| χ22b | 83.8* | 13.4* | 47.2* | |||||||||
| χ24 for Treatment Type=12.6*c | ||||||||||||
*
Significant at the .05 level, two sided test.
a
Reference group for the dependent variable in the logistic regressions was a “no treatment” group.
b
This chi-square evaluates the significance of the strength of the association between the predictor and the dependent variable (i.e., treatment group vs. no treatment group).
c
This chi-square evaluates the significance of the difference in the strength of association between the predictor and the dependent variable (treatment group) across the three different types of treatment.